NKTR-102 100 mg/m2
07-PIR-02
Phase 2 small_molecule completed
Quick answer
NKTR-102 100 mg/m2 for Tumor is a Phase 2 program (small_molecule) at Nektar Therapeutics UK Limited with 1 ClinicalTrials.gov record(s).
Program details
- Company
- Nektar Therapeutics UK Limited
- Indication
- Tumor
- Phase
- Phase 2
- Modality
- small_molecule
- Status
- completed